- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Medical Assn Won't Stop Medicare Doc Data Release
The nation's largest doctors' group said Monday it won't try to block Medicare's release of billing records for 880,000 physicians, although it continues to oppose the government's recent decision to open up the massive data trove.
The nation’s largest doctors’ group said Monday it won’t try to block Medicare’s release of billing records for 880,000 physicians, although it continues to oppose the government’s recent decision to open up the massive data trove.
An official of the American Medical Association told The Associated Press that the group won’t go to court ahead of Wednesday’s scheduled release. The official spoke on condition of anonymity because the organization’s policies allow only certain designated representatives to make on-the-record comments.
Considered the mother lode of information on doctors, the Medicare claims database has been off-limits to the public for decades, blocked in the courts by physician groups who argue its release would do more harm than good.
Read the full story here: http://wapo.st/Ox6Kn7
Source: The Washington Post
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
AXS25: Health Policy, Drug Costs, and AI Highlights From the Conference
May 6th 2025Asembia’s AXS25 Summit covered a variety of relevant topics in the pharmaceutical industry, from the effects of the new administration to how artificial intelligence (AI) is reshaping the patience experience.
Read More
